ClinicalTrials.Veeva

Menu

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Terminated

Conditions

Bladder Cancer

Treatments

Other: Observation
Procedure: Surveillance Cystoscopy and Urinary Cytology
Other: Immediate Surgery

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This trial is a randomized, multi-center, non-inferiority study comparing observation versus immediate surgery for low grade, noninvasive bladder cancer.

Enrollment

8 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of low grade, noninvasive urothelial carcinoma of the bladder with a new recurrence that meets the following criteria:
  • total tumor burden ≤3cm in size (multiple lesions permitted)
  • low grade appearance (grade 1 or grade 2)
  • noninvasive appearance (Ta)
  • no history of carcinoma in situ (CIS) or lesions concerning for CIS
  • negative urine cytology (atypical or suspicious for low grade neoplasm are acceptable)

Exclusion criteria

  • High grade and/or invasive and/or carcinoma in situ disease
  • Concomitant upper tract urothelial carcinoma
  • Any patient who is pregnant or who may have plans to become pregnant.
  • Positive cytology

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8 participants in 2 patient groups

Observation
Other group
Description:
Patients will not undergo immediate surgery. These patients will undergo surveillance cystoscopy and urinary cytology every 3 months for 12 months. Surgery will commence after 12 months of observation or sooner if cystoscopic evidence of disease progression or patient desire.
Treatment:
Procedure: Surveillance Cystoscopy and Urinary Cytology
Other: Observation
Immediate Surgery
Other group
Description:
Patients will undergo immediate surgery. These patients will undergo surveillance cystoscopy and urinary cytology every 3 months for 12 months. Repeated surgery will be offered for additional recurrences.
Treatment:
Other: Immediate Surgery
Procedure: Surveillance Cystoscopy and Urinary Cytology

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems